News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
846,143 Results
Type
Article (86410)
Company Profile (651)
Press Release (759082)
Multimedia
Podcasts (131)
Webinars (14)
Section
Business (232641)
Career Advice (4127)
Deals (39721)
Drug Delivery (129)
Drug Development (90938)
Employer Resources (198)
FDA (18088)
Job Trends (17338)
News (396340)
Policy (39736)
Tag
Academia (2998)
Academic (1)
Accelerated approval (6)
Adcomms (26)
Allergies (93)
Alliances (56830)
ALS (103)
Alzheimer's disease (1498)
Antibody-drug conjugate (ADC) (158)
Approvals (18056)
Artificial intelligence (303)
Autoimmune disease (28)
Automation (16)
Bankruptcy (403)
Best Places to Work (12616)
BIOSECURE Act (22)
Biosimilars (120)
Biotechnology (448)
Bladder cancer (82)
Brain cancer (30)
Breast cancer (304)
Cancer (2438)
Cardiovascular disease (206)
Career advice (3534)
Career pathing (34)
CAR-T (173)
Cell therapy (486)
Cervical cancer (21)
Clinical research (73409)
Collaboration (922)
Company closure (2)
Compensation (569)
Complete response letters (28)
COVID-19 (2863)
CRISPR (50)
C-suite (270)
Cystic fibrosis (107)
Data (2353)
Decentralized trials (2)
Denatured (46)
Depression (52)
Diabetes (284)
Diagnostics (6912)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (131)
Drug pricing (123)
Drug shortages (29)
Duchenne muscular dystrophy (103)
Earnings (96928)
Editorial (45)
Employer branding (25)
Employer resources (167)
Events (130080)
Executive appointments (768)
FDA (19490)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (810)
Gene editing (125)
Generative AI (26)
Gene therapy (361)
GLP-1 (838)
Government (5162)
Grass and pollen (5)
Guidances (150)
Healthcare (20866)
Huntington's disease (26)
IgA nephropathy (30)
Immunology and inflammation (145)
Indications (30)
Infectious disease (3015)
Inflammatory bowel disease (158)
Inflation Reduction Act (11)
Influenza (56)
Intellectual property (101)
Interviews (813)
IPO (17825)
IRA (48)
Job creations (5190)
Job search strategy (2861)
Kidney cancer (11)
Labor market (47)
Layoffs (562)
Leadership (23)
Legal (10102)
Liver cancer (82)
Lung cancer (342)
Lymphoma (160)
Machine learning (9)
Management (65)
Manufacturing (359)
MASH (80)
Medical device (14609)
Medtech (14614)
Mergers & acquisitions (22440)
Metabolic disorders (776)
Multiple sclerosis (87)
NASH (23)
Neurodegenerative disease (113)
Neuropsychiatric disorders (33)
Neuroscience (2099)
NextGen: Class of 2025 (7667)
Non-profit (5079)
Now hiring (41)
Obesity (414)
Opinion (273)
Ovarian cancer (83)
Pain (100)
Pancreatic cancer (91)
Parkinson's disease (158)
Partnered (23)
Patents (254)
Patient recruitment (119)
Peanut (51)
People (65283)
Pharmaceutical (133)
Pharmacy benefit managers (22)
Phase I (22661)
Phase II (31888)
Phase III (24008)
Pipeline (1385)
Policy (175)
Postmarket research (3551)
Preclinical (10230)
Press Release (72)
Prostate cancer (111)
Psychedelics (37)
Radiopharmaceuticals (267)
Rare diseases (425)
Real estate (7391)
Recruiting (75)
Regulatory (26786)
Reports (58)
Research institute (2653)
Resumes & cover letters (649)
Rett syndrome (5)
RNA editing (5)
RSV (44)
Schizophrenia (80)
Series A (143)
Series B (93)
Service/supplier (27)
Sickle cell disease (59)
Special edition (20)
Spinal muscular atrophy (165)
Sponsored (34)
Startups (4294)
State (2)
Stomach cancer (14)
Supply chain (70)
Tariffs (54)
The Weekly (83)
Vaccines (812)
Venture capitalists (45)
Weight loss (288)
Women's health (41)
Worklife (20)
Date
Today (190)
Last 7 days (970)
Last 30 days (3221)
Last 365 days (34477)
2025 (12265)
2024 (37556)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1270)
Alabama (61)
Alaska (7)
Arizona (267)
Arkansas (14)
Asia (50140)
Australia (8832)
California (6615)
Canada (2093)
China (569)
Colorado (285)
Connecticut (290)
Delaware (164)
Europe (114966)
Florida (969)
Georgia (221)
Hawaii (1)
Idaho (64)
Illinois (616)
India (29)
Indiana (333)
Iowa (12)
Japan (175)
Kansas (113)
Kentucky (26)
Louisiana (14)
Maine (67)
Maryland (984)
Massachusetts (5039)
Michigan (236)
Minnesota (425)
Mississippi (2)
Missouri (84)
Montana (30)
Nebraska (26)
Nevada (69)
New Hampshire (67)
New Jersey (1858)
New Mexico (30)
New York (1856)
North Carolina (1135)
North Dakota (9)
Northern California (2858)
Ohio (216)
Oklahoma (15)
Oregon (46)
Pennsylvania (1455)
Puerto Rico (14)
Rhode Island (35)
South America (1653)
South Carolina (25)
South Dakota (1)
Southern California (2452)
Tennessee (106)
Texas (984)
United States (25137)
Utah (194)
Virginia (165)
Washington D.C. (69)
Washington State (604)
West Virginia (3)
Wisconsin (60)
846,143 Results for "kronos bio inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Kronos Accepts $35M Concentra Buyout as Walls Close In
After multiple rounds of layoffs that cut Kronos down to just 10 people, the small molecule biotech has accepted a buyout offer from Kevin Tang’s Concentra Biosciences.
May 2, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Kronos Bio Enters into Agreement to Be Acquired by Concentra Biosciences for $0.57 in Cash per Share Plus a Contingent Value Right
May 1, 2025
·
6 min read
Press Releases
Kronos Bio Reports Fourth Quarter and Full Year 2024 Financial Results
March 18, 2025
·
3 min read
Biotech Bay
Kronos Bio to Participate in Three Upcoming Healthcare Conferences and Events
Kronos Bio, Inc. today announced that the company would participate in three upcoming healthcare conferences and events.
May 22, 2024
·
1 min read
Business
Kronos Bio Reports First-Quarter 2024 Financial Results
Kronos Bio, Inc. reported recent business progress and financial results for the first-quarter of 2024.
May 9, 2024
·
7 min read
Press Releases
Kronos Advanced Technologies Inc. ($KNOS) Confirms Ownership and Shareholder Updates for KronosMD, Inc.
January 27, 2025
·
13 min read
Press Releases
Kronos Bio Announces CEO Transition and Reduction in Force
November 27, 2024
·
4 min read
Business
Kronos Bio Appoints Deborah Knobelman, Ph.D. as Chief Operating Officer and Chief Financial Officer
Kronos Bio, Inc. today announced that it has appointed Deborah Knobelman, Ph.D., as Chief Operating Officer and Chief Financial Officer effective June 3, 2024.
May 21, 2024
·
3 min read
Business
Kronos Bio Implements New Leadership Structure to Drive Pipeline Advancement
Kronos Bio, Inc., a company dedicated to transforming the lives of those affected by cancer, announced a streamlined leadership structure designed to focus on pipeline advancement and align with Kronos Bio’s current operating needs.
January 25, 2024
·
6 min read
Press Releases
Kronos Bio Reports Third Quarter 2024 Financial Results and Corporate Update Including Plan to Evaluate Strategic Alternatives
November 14, 2024
·
8 min read
1 of 84,615
Next
